U.S. Officials Advance Plan on Specialty Pharmacy Peptide Injections
U.S. health officials have advanced a plan to allow specialty pharmacies to produce certain largely unregulated peptide injections, a move favored by Health Secretary Robert F. Kennedy Jr. and popular with wellness influencers. The interim access policy has been submitted…
Orlando Daytona Beach Melbourne, FL, October 15, 2026 —
U.S. health officials have advanced an interim policy that would allow specialty pharmacies to produce certain peptide injections. The policy has been submitted to the White House for review and could ease access to the products if it proceeds.
The injections are described as largely unregulated and unproven. The plan is favored by Health Secretary Robert F. Kennedy Jr. and has gained popularity among wellness influencers, according to the information provided.
The submission marks a step in the policy process, but the White House’s response has not been reported. It is also unclear from the available information when a decision might be made or what additional steps would be required before the policy could take effect.
The proposal’s scope has not been specified. The names of the peptides involved, the conditions for which they might be produced, and any limits on pharmacy production were not provided. Details about how the policy would address the products’ regulatory status or evidence of effectiveness were also not available.
The plan concerns an interim access policy; the information provided does not establish that the policy has been approved or that pharmacies are currently authorized to produce the injections under it. Further details about the review and the policy’s potential implementation were not provided.
Story summarized from the original created by Matthew Perrone, Associated Press on www.clickorlando.com, see more information here.
Media gallery
